Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2025-12-25 @ 11:33 PM
NCT ID: NCT02287493
Description: Serious, and Other (Not Including Serious) Adverse Events were not monitored/assessed. Mortality was not considered to be a Serious Adverse Event.
Frequency Threshold: 0
Time Frame: Serious, and Other (Not Including Serious) Adverse Events were not monitored/assessed. Mortality was not considered to be a Serious Adverse Event.
Study: NCT02287493
Study Brief: Pharmacokinetics of Selected Antiinfectives During Sustained Low-efficiency Dialysis (SLED)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Meropenem Adult ICU patients receiving meropenem during SLED will be analyzed for meropenem pharmacokinetics. None None 0 0 0 0 View
Ceftazidim Adult ICU patients receiving ceftazidim during SLED will be analyzed for ceftazidim pharmacokinetics. None None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):